International Publisher of Science, Technology and Medicine

 
 
Share this
 
 
 
Track Your Manuscript
 
 
 
 
Journal of Immunological Techniques in Infectious Diseases
Editorial Board: David H. Van Thiel, MD
Rush University Medical Center, USA view all
ISSN: 2329-9541
NLM ID: 101611071
Frequency: Quarterly
 
 

The Journal of Immunological Techniques in Infectious Diseases(JIDIT) is a scholarly peer-reviewed journal that encourages rigorous research that makes a significant contribution in advancing knowledge for techniques used for detection, prevention & treatment of emerging infectious diseases. JIDIT includes all major themes pertaining to Infectious diseases like Diagnostic techniques, epidemiology, immune response, vaccination etc.

Scope of the Journal includes:

Journal of Immunological Techniques in Infectious Diseases is a subscription based scientific Journal that provides a range of options to individuals and university libraries to purchase our articles and also permits unlimited Internet Access to complete Journal content. However JIDIT has recently started following Hybrid Model of publication of articles. Under hybrid model, journal is giving option to authors to choose their mode of publishing; either Open Access (making individual articles freely available online) or Subscription (article access restricted to journal subscribers).

JIDIT accepts wide range of articles including research, review, short communication, case report, rapid communication, letter to the editor, conference proceedings etc. The journal has a sound Editorial Board of experts in their fields. Articles submitted by authors are evaluated by Editors and a group of peer review experts in the field to ensure that the accepted and published articles are of high quality, reflect solid scholarship in their fields, and that the information they contain is accurate, reliable and beneficial to the scientific community.

Manuscripts along with cover letters can be submitted to the journal via online submission system or as an e-mail attachment to the Editorial Office at editor.jidit@scitechnol.com or editor.jidit@scitechnol.org or editor.jidit@scitechnol.net. Authors can also track the status of their manuscripts post submission through our manuscript tracking system.

Journal of Immunological Techniques in Infectious Diseases is organizing & supporting 4th International Conference on Vaccines & Vaccination which is going to be held during September 24-26, 2014 at Valencia, Spain with the theme of Recent Innovations and Benchmark Practices in Vaccines & Vaccination.

 

 
Current Issue
Secondary Syphilis Mimicking Leprosy Type1 Reaction   Case Report
Cassio Porto Ferreira, Vinicius Medeiros, Raquel Cristina Maia, Anna Maria Sales and Jose Augusto Da Costa Nery
J Immunol Tech Infect Dis 2015, 4:1    doi: 10.4172/2329-9541.1000129
Preview

Secondary Syphilis Mimicking Leprosy Type1 Reaction

Syphilis and leprosy have cutaneous manifestations with great lesional polymorphism with subsequent difficult differential diagnosis. Both have additional tests that, in certain situations, are inconclusive, making it difficult to confirm the clinical diagnosis. In medical literature there are several clinical cases reported in which patients with syphilis were erroneously diagnosed and treated as having leprosy. Physicians need to maintain a high index of suspicion for the diagnosis of syphilis.

| Full Text | PDF   
Late-Onset Prosthetic Valve Fungal Endocarditis due to Candida albicans: A Case Report and Review of Literature from India   Case Report
Jain Sarika, Sharma Bhawna, Gaind Rajni, Capoor Malini R and Deb Manorama
J Immunol Tech Infect 2015, 4:1    doi: 10.4172/2329-9541.1000130
Preview

Late-Onset Prosthetic Valve Fungal Endocarditis due to Candida albicans: A Case Report and Review of Literature from India

The incidence of prosthetic valve endocarditis (PVE) is 1-4%. Fungal endocarditis (FE) is an uncommon complication of valve replacement surgery. The incidence of PVE is highest within the first 12 months following surgery. We report here a fatal case of late-onset fungal endocarditis after 15 years of mitral valve replacement for which administration of amphotericin B is crucial for survival of patients.

| Full Text | PDF   
Prospect of CD52 Targeted Alemtuzumab in Treatment of CNS Demyelination in Multiple Sclerosis   Review Article
Subhajit Dasgupta and Mausumi Bandyopadhyay
J Immunol Tech Infect Dis 2015, 4:1    doi: 10.4172/2329-9541.1000131
Preview

Prospect of CD52 Targeted Alemtuzumab in Treatment of CNS Demyelination in Multiple Sclerosis

The choice of humanized monoclonal antibody is a novel therapeutic approach for autoimmune relapsing remitting multiple sclerosis (RRMS). In addition to anti-alpha-4 integr in monoclonal antibody Natalizumab, introduction of CAMPATH-1 (Alemtuzumab) is a fairly new approach in MS research and clinical trials. The uniqueness of this monoclonal antibodyis that it depletes CD52 marker expressing circulatory T and B cells including monocytes and dendritic cells. However, it has no impact on progenitor cells. Thus, the use of Alemtuzumab has gained importance in delaying rejection in allograft during transplantation.

| Full Text | PDF